Ph. Kass et al., USE OF TRANSCUTANEOUS BILIRUBINOMETRY AS A SCREENING AND MONITORING INSTRUMENT FOR HYPERBILIRUBINEMIA IN CATS AND DOGS, Canine practice, 23(5), 1998, pp. 12-15
A hospital-based study was conducted to determine the efficacy of tran
scutaneous bilirubinometry for screening dogs and cats for diseases re
sulting in hyperbilirubinemia, and for predicting total serum bilirubi
n values. The study was conducted at the University of California, Dav
is Veterinary Medical Teaching Hospital (VMTH) for a period of approxi
mately 2 years that ended in October 1994. Cats and dogs were eligible
for participation if they were patients during this time, and had a c
hemistry panel performed as part of their complete medical study. The
measurements were performed using a Minolta/Air Shields Jaundice Meter
101 and taken at four sites on the body. All transcutaneous readings
were performed within 24 hours of serum measurements. Although the met
er served as a useful screening device for hyperbilirubinemia in dogs,
simultaneously achieving relatively high sensitivities and negative p
redictive values, if was less effective in cats for this purpose. At f
etal serum bilirubin levels above 1.0 mg/dl in particular, however, if
was possible to construct regression models that provided excellent f
its while controlling for species and the presence of skin pigmentatio
n (e.g., for earflap readings, r = 0.96 (P < 0.00001). This study docu
ments that transcutaneous bilirubinometry holds promise beyond human n
eonatal medicine to diagnostic veterinary medicine for temporal monito
ring of elevated bilirubin values and, in dogs, for screening.